Related Experiment Video
Updated: Mar 1, 2026

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
Published on: July 3, 2025
Oncostatin M induces RIG-I and MDA5 expression and enhances the double-stranded RNA response in fibroblasts
Sabine Hergovits1, Christine Mais1, Claude Haan2
1Medical Clinic and Policlinic II, Division of Hepatology, University Hospital Würzburg, Würzburg, Germany.
Abstract:
Interleukin (IL)-6-type cytokines have no direct antiviral activity; nevertheless, they display immune-modulatory functions. Oncostatin M (OSM), a member of the IL-6 family, has recently been shown to induce a distinct number of classical interferon stimulated genes (ISG). Most of them are involved in antigen processing and presentation. However, induction of retinoic acid-inducible gene (RIG)-I-like receptors (RLR) has not been investigated. Here we report that OSM has the capability to induce the expression of the DExD/H-Box RNA helicases RIG-I and melanoma differentiation antigen 5 (MDA5) as well as of the transcription factors interferon regulatory factor (IRF)1, IRF7 and IRF9 in primary fibroblasts. Induction of the helicases depends on tyrosine as well as serine phosphorylation of STAT1. Moreover, we could show that the OSM-induced STAT1 phosphorylation is predominantly counter-regulated by a strong STAT3-dependent SOCS3 induction, as Stat3 as well as Socs3 knock-down results in an enhanced and prolonged helicase and IRF expression. Other factors involved in regulation of STAT1 or IRF1 activity, like protein tyrosine phosphatase, non-receptor type 2 (PTPN2), promyelocytic leukaemia protein (PML) or small ubiquitin-related modifier 1 (SUMO1), play a minor role in OSM-mediated induction of RLR. Remarkably, OSM and interferon-γ (IFN-γ) synergize to mediate transcription of RLR and pre-treatment of fibroblasts with OSM fosters the type I interferon production in response to a subsequent encounter with double-stranded RNA. Together, these findings suggest that the OSM-induced JAK/STAT1 signalling is implicated in virus protection of non-professional immune cells and may cooperate with interferons to enhance RLR expression in these cells.
Insights
Oncostatin M (OSM) induces antiviral genes RIG-I-like receptors (RLR) in fibroblasts via STAT1 signaling. This pathway enhances cellular antiviral defense and cooperates with interferons, suggesting a role in virus protection.
Area of Science:
- Immunology
- Virology
- Cellular Biology
Background:
- Interleukin-6 (IL)-6-type cytokines modulate immune responses but lack direct antiviral activity.
- Oncostatin M (OSM), an IL-6 family member, induces interferon-stimulated genes (ISGs), primarily involved in antigen presentation.
- The induction of retinoic acid-inducible gene (RIG)-I-like receptors (RLRs) by OSM has not been previously investigated.
Purpose of the Study:
- To investigate the capability of Oncostatin M (OSM) to induce retinoic acid-inducible gene (RIG)-I-like receptors (RLRs) in primary fibroblasts.
- To elucidate the signaling pathways and regulatory mechanisms involved in OSM-mediated RLR induction.
- To assess the functional implications of OSM-induced RLR expression in cellular antiviral defense.
Main Methods:
- Primary human fibroblasts were treated with OSM to assess gene expression.
- Western blotting and gene knockdown techniques were used to analyze signaling pathways, including STAT1, STAT3, and SOCS3.
- Synergistic effects of OSM with interferon-gamma (IFN-γ) on RLR transcription were evaluated.
- The impact of OSM pre-treatment on type I interferon production upon double-stranded RNA stimulation was assessed.
Main Results:
- OSM induced the expression of RIG-I-like receptors (RLRs), including RIG-I and MDA5, and transcription factors IRF1, IRF7, and IRF9 in primary fibroblasts.
- The induction of these genes was dependent on both tyrosine and serine phosphorylation of STAT1.
- STAT3-dependent SOCS3 induction counter-regulated OSM-induced STAT1 phosphorylation, with STAT3 and SOCS3 knockdown enhancing RLR and IRF expression.
- OSM and IFN-γ synergistically mediated RLR transcription, and OSM pre-treatment enhanced type I interferon production in response to double-stranded RNA.
Conclusions:
- OSM induces RLR expression in fibroblasts through JAK/STAT1 signaling, contributing to cellular antiviral defense.
- STAT3-dependent SOCS3 acts as a key negative regulator of this OSM-induced pathway.
- OSM-induced signaling cooperates with interferons to enhance RLR expression, suggesting a role in non-professional immune cells' virus protection.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Induced Pluripotent Stem Cells
Somatic...
PI3K/mTOR/AKT Signaling Pathway
Experimental RNAi
MAPK Signaling Cascades
Abnormal Proliferation

